Human HLA-DPB2 CRISPR gRNA + Cas9 in Lenti Particles
Quick Overview for Human HLA-DPB2 CRISPR gRNA + Cas9 in Lenti Particles (ABIN5296096)
Gene
Application
Insert
Vector
Vector Backbone
Promoter
Bacterial Resistance
Expression Type
-
-
Species
- Human
-
Purpose
- Set of 3 gRNA against HLA-DPB2 in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (sgRNA and Cas9 in a single vector)
-
Sequence
- Sequence available upon placing order
-
Specificity
-
GRNAs are designed for use with Cas9 Nuclease only.
Cas9 Nuclease is under the control of the SFFV promoter which should work for a vast majority of cells, except ES cells or iPS cells. -
Components
- Lentiviral particles with a set of 3 gRNAs (3 x 300 μL) covering different sequences of HLA-DPB2
-
Selectable Marker
- Puromycin
-
Sequencing Primer
- U6 Forward Primer: 5'--TACGTCCAAGGTCGGGCAGGAAGA--3'
-
-
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- HLA-DPB2 (Major Histocompatibility Complex, Class II, DP beta 2 (Pseudogene) (HLA-DPB2))
-
Alternative Name
- HLA-DPB2
-
NCBI Accession
- NR_001435
Target
-